Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    95.00 (0.70%)
Bid:
13,580.00
Ask:
13,590.00
Spread: 10.00 (0.074%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Trading Statement

31 Oct 2018 07:00

RNS Number : 7808F
Next PLC
31 October 2018
 

Date:

Embargoed until 07.00hrs, Wednesday 31 October 2018

 

 

Contacts:

Amanda James, Group Finance Director (analyst calls)

 

NEXT PLC

Tel: 0333 777 8888

 

 

 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

 

Rowbell PR

Tel: 020 7717 5239

 

 

Photographs:

http://www.nextplc.co.uk/media/image-gallery/campaign-images

 

Next plc

Trading Statement - 31 October 2018

 

SALES FOR THE YEAR TO 27 OCTOBER 2018

Full Price Sales for the Third Quarter and Year to Date

Full price sales in the third quarter were up +2.0% on last year, in line with our expectations. The table below sets out the sales performance for Retail, Online and our Finance business interest income for the third quarter and year to date. 

Full price sales (VAT exclusive)

Third quarter

to 27 Oct

Year to date

Retail

- 8.0%

- 6.3%

Online

+12.7%

+14.8%

Product full price sales

+1.3%

+3.1%

Finance interest income1

+11.9%

+12.3%

Total full price sales including interest income

+2.0%

+3.7%

Of which sales from new space

+0.6%

+0.5%

 

1 Interest income is the gross interest billed to nextpay customers.

 

FULL PRICE SALES AND PROFIT GUIDANCE FOR THE FULL YEAR

We are maintaining the full year sales and profit guidance that we set out five weeks ago in our Half Year Results. For completeness, this is shown in the table below.

Full year estimate to January 2019

Central guidance

Total full price sales versus 2017/18

+3.0%

Group profit before tax

£727m

Group profit before tax versus 2017/18

+0.1%

Earnings Per Share growth versus 2017/18

+5.0%

CHRISTMAS TRADING STATEMENT

We intend to issue our usual update for sales to 24 December 2018 on Thursday 3 January 2019.

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVBLFXVBFXFBB
Date   Source Headline
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights
12th Jul 20235:08 pmRNSTransaction in Own Shares
11th Jul 20235:46 pmRNSTransaction in Own Shares
10th Jul 20235:14 pmRNSTransaction in Own Shares
7th Jul 20235:10 pmRNSTransaction in Own Shares
6th Jul 20235:44 pmRNSTransaction in Own Shares
5th Jul 20235:43 pmRNSTransaction in Own Shares
4th Jul 20235:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.